145
Views
46
CrossRef citations to date
0
Altmetric
Review

Novel targeted therapies in chordoma: an update

, , , , , & show all
Pages 873-883 | Published online: 26 May 2015

References

  • Central Brain Tumor Registry of the United StatesCBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004–2007Hinsdale (IL)CBTRUS2011
  • ChughRTawbiHLucasDRBiermannJSSchuetzeSMBakerLHChordoma: the nonsarcoma primary bone tumorOncologist200712111344135018055855
  • ChambersKJLinDTMeierJRemenschneiderAHerrMGraySTIncidence and survival patterns of cranial chordoma in the United StatesLaryngoscope201412451097110224122844
  • McMasterMLGoldsteinAMBromleyCMIshibeNParryDMChordoma: incidence and survival patterns in the United States, 1973–1995Cancer Causes Control200112111111227920
  • AlOtaibiFGuiotMCMuanzaTDi MaioSGiant petroclival primary intradural chordoma: case report and systematic review of the literatureJ Neurol Surg Rep2014751e160e16925083378
  • GoldenLDSmallJEBenign notochordal lesions of the posterior clivus: retrospective review of prevalence and imaging characteristicsJ Neuroimaging201424324524923464492
  • GeorgeBBressonDBouazzaSChordomaNeuro-Chirurgie201460363140 French24856008
  • MirraJMNelsonSDDella RoccaCMertensFChordomaFletcherDMUnniKMertensFPathology and Genetics of Tumours of Soft Tissue and BoneLyonIARC Press2002316317
  • WalcottBPNahedBVMohyeldinACoumansJVKahleKTFerreiraMJChordoma: current concepts, management, and future directionsLancet Oncol2012132e69e7622300861
  • McMasterMUpdate on the epidemiology of chordoma: SEER registry data 1973–2007Poster presented at: Third International Chordoma Research Workshop317–192011Bethesda, MD
  • Di MaioSTemkinNRamanathanDSekharLNCurrent comprehensive management of cranial base chordomas: 10-year meta-analysis of observational studiesJ Neurosurg201111561094110521819197
  • YasudaMBressonDChibbaroSChordomas of the skull base and cervical spine: clinical outcomes associated with a multimodal surgical resection combined with proton-beam radiation in 40 patientsNeurosurg Rev2012352171182 discussion 182–18321863225
  • Fernandez-MirandaJCGardnerPASnydermanCHClival chordomas: a pathological, surgical, and radiotherapeutic reviewHead Neck201436689290623804541
  • DiazRJCusimanoMDThe biological basis for modern treatment of chordomaJ Neurooncol2011104241142221384217
  • BorianiSBandieraSBiaginiRChordoma of the mobile spine: fifty years of experienceSpine (Phila Pa 1976)200631449350316481964
  • JawadMUScullySPSurgery significantly improves survival in patients with chordomaSpine (Phila Pa 1976)201035111712320042964
  • Di MaioSSekharLNSkull base approachesEllenbogenRGAbdulraufSIPrinciples of Neurological Surgery: Expert Consult – Online and PrintPhiladelphiaElsevier2012
  • RostomilyRCSekharLNElahiFChordomas and chondrosarcomasSekharLNFesslerRAtlas of Neurosurgical TechniquesBrainNew YorkThieme2006
  • TanNCNaidooYOueSEndoscopic surgery of skull base chordomasJ Neurol Surg B Skull Base201273637938624294554
  • ChibbaroSCorneliusJFFroelichSEndoscopic endonasal approach in the management of skull base chordomas – clinical experience on a large series, technique, outcome, and pitfallsNeurosurg Rev2014372217224 discussion 224–21524249430
  • SaitoKTodaMTomitaTOgawaKYoshidaKSurgical results of an endoscopic endonasal approach for clival chordomasActa Neurochir (Wien)2012154587988622402876
  • FraserJFNyquistGGMooreNAnandVKSchwartzTHEndoscopic endonasal transclival resection of chordomas: operative technique, clinical outcome, and review of the literatureJ Neurosurg201011251061106919698043
  • DehdashtiARKarabatsouKGannaAWitterickIGentiliFExpanded endoscopic endonasal approach for treatment of clival chordomas: early results in 12 patientsNeurosurgery2008632299307 discussion 307–30918797360
  • JiangWHZhaoSPXieZHZhangHZhangJXiaoJYEndoscopic resection of chordomas in different clival regionsActa Otolaryngol20091291718318607890
  • ZhangQKongFYanBNiZLiuHEndoscopic endonasal surgery for clival chordoma and chondrosarcomaORL J Otorhinolaryngol Relat Spec200870212412918408411
  • FrankGSciarrettaVCalbucciFFarnetiGMazzatentaDPasquiniEThe endoscopic transnasal transsphenoidal approach for the treatment of cranial base chordomas and chondrosarcomasNeurosurgery2006591 Suppl 1ONS50ONS5716888551
  • FatemiNDusickJRGorgulhoAAEndonasal microscopic removal of clival chordomasSurg Neurol200869433133818234296
  • Fernandez-MirandaJCGardnerPARastelliMMJrEndoscopic endonasal transcavernous posterior clinoidectomy with interdural pituitary transpositionJ Neurosurg20141211919924816325
  • KomotarRJStarkeRMRaperDMAnandVKSchwartzTHThe endoscope-assisted ventral approach compared with open microscope-assisted surgery for clival chordomasWorld Neurosurg2011763–4318327 discussion 259–36221986431
  • KoutourousiouMGardnerPATormentiMJEndoscopic endo-nasal approach for resection of cranial base chordomas: outcomes and learning curveNeurosurgery2012713614624 discussion 624–62522592328
  • JonesPSAghiMKMuzikanskyAShihHABarkerFG2ndCurryWTJrOutcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and End Results (SEER) databaseJ Clin Neurosci20142191490149624852903
  • BohmanLEKochMBaileyRLAlonso-BasantaMLeeJYSkull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis; a SEER analysisWorld Neurosurg201482580681425009165
  • OikawaSKyoshimaKGotoTHistological study on local invasiveness of clival chordoma. Case report of autopsyActa Neurochir (Wien)2001143101065106911685615
  • NakaTBoltzeCKuesterDIntralesional fibrous septum in chordoma: a clinicopathologic and immunohistochemical study of 122 lesionsAm J Clin Pathol2005124228829416040302
  • JianBJBlochOGYangIHanSJArandaDParsaATA comprehensive analysis of intracranial chordoma and survival: a systematic reviewBr J Neurosurg201125444645321749184
  • TzortzidisFElahiFWrightDNatarajanSKSekharLNPatient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomasNeurosurgery200659223023716883163
  • Di MaioSRostomilyRSekharLNCurrent surgical outcomes for cranial base chordomas: cohort study of 95 patientsNeurosurgery20127061355136022157545
  • PearlmanAWFriedmanMRadical radiation therapy of chordomaAm J Roentgenol Radium Ther Nucl Med19701082332341
  • MunzenriderJELiebschNJProton therapy for tumors of the skull baseStrahlenther Onkol1999175Suppl 2576310394399
  • BradaMPijls-JohannesmaMDe RuysscherDCurrent clinical evidence for proton therapyCancer J200915431932419672149
  • HugEBLoredoLNSlaterJDProton radiation therapy for chordomas and chondrosarcomas of the skull baseJ Neurosurg199991343243910470818
  • CastroJRLinstadtDEBaharyJPExperience in charged particle irradiation of tumors of the skull base: 1977–1992Int J Radiat Oncol Biol Phys19942946476558040010
  • AmichettiMCianchettiMAmelioDEnriciRMMinnitiGProton therapy in chordoma of the base of the skull: a systematic reviewNeurosurg Rev200932440341619319583
  • Schulz-ErtnerDKargerCPFeuerhakeAEffectiveness of carbon ion radiotherapy in the treatment of skull-base chordomasInt J Radiat Oncol Biol Phys200768244945717363188
  • OstroumovEHunterCJThe role of extracellular factors in human metastatic chordoma cell growth in vitroSpine (Phila Pa 1976)200732262957296418091487
  • DuranteMLoefflerJSCharged particles in radiation oncologyNat Rev Clin Oncol201071374319949433
  • TakahashiSKawaseTYoshidaKHasegawaAMizoeJESkull base chordomas: efficacy of surgery followed by carbon ion radiotherapyActa Neurochir (Wien)2009151775976919434365
  • NikoghosyanAVKarapanagiotou-SchenkelIMünterMWJensenADCombsSEDebusJRandomised trial of proton vs carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-StudyBMC Cancer20101060721054824
  • MimaMDemizuYJinDParticle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordomaBr J Radiol20148710332013051224288399
  • PeetersAGruttersJPPijls-JohannesmaMHow costly is particle therapy? Cost analysis of external beam radiotherapy with carbonions, protons and photonsRadiother Oncol2010951455320106540
  • TorresMAChangELMahajanAOptimal treatment planning for skull base chordoma: photons, protons, or a combination of both?Int J Radiat Oncol Biol Phys20097441033103919356861
  • FeuvretLNoelGWeberDCA treatment planning comparison of combined photon-proton beams versus proton beams-only for the treatment of skull base tumorsInt J Radiat Oncol Biol Phys200769394495417889276
  • BugociDMGirvigianMRChenJCMillerMMRahimianJPhoton-based fractionated stereotactic radiotherapy for postoperative treatment of skull base chordomasAm J Clin Oncol201336440441022772429
  • DebusJSchulz-ErtnerDSchadLStereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull baseInt J Radiat Oncol Biol Phys200047359159610837940
  • KanoHIqbalFOSheehanJStereotactic radiosurgery for chordoma: a report from the North American Gamma Knife ConsortiumNeurosurgery201168237938921135744
  • KanoHLunsfordLDStereotactic radiosurgery of intracranial chordomas, chondrosarcomas, and glomus tumorsNeurosurg Clin N Am201324455356024093573
  • KrishnanSFooteRLBrownPDPollockBELinkMJGarcesYIRadiosurgery for cranial base chordomas and chondrosarcomasNeurosurgery200556477778415792516
  • LiuALWangZCSunSBWangMHLuoBLiuPGamma knife radiosurgery for residual skull base chordomasNeurol Res200830655756118647493
  • HasegawaTIshiiDKidaYYoshimotoMKoikeJIizukaHGamma knife surgery for skull base chordomas and chondrosarcomasJ Neurosurg2007107475275717937219
  • TeraharaANiemierkoAGoiteinMAnalysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordomaInt J Radiat Oncol Biol Phys199945235135810487555
  • O’ConnellJXRenardLGLiebschNJEfirdJTMunzenriderJERosenbergAEBase of skull chordoma. A correlative study of histologic and clinical features of 62 casesCancer1994748226122677922977
  • PotluriSJefferiesSJJenaRResidual postoperative tumour volume predicts outcome after high-dose radiotherapy for chordoma and chondrosarcoma of the skull base and spineClin Oncol (R Coll Radiol)201123319920820980136
  • AresCHugEBLomaxAJEffectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term reportInt J Radiat Oncol Biol Phys20097541111111819386442
  • HorbinskiCOakleyGJCieplyKThe prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomasArch Pathol Lab Med201013481170117620670138
  • KitamuraYSasakiHKimuraTMolecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosisJ Neuropathol Exp Neurol201372981682323965741
  • SinghalNKotasekDParnisFXResponse to erlotinib in a patient with treatment refractory chordomaAnticancer Drugs2009201095395519730087
  • VujovicSHendersonSPresneauNBrachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomasJ Pathol2006209215716516538613
  • RomeoSHogendoornPCBrachyury and chordoma: the chondroid-chordoid dilemma resolved?J Pathol2006209214314616604512
  • SchwabJHBolandPJAgaramNPChordoma and chondrosar-coma gene profile: implications for immunotherapyCancer Immunol Immunother200958333934918641983
  • PresneauNShalabyAYeHRole of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based studyJ Pathol2011223332733521171078
  • HsuWMohyeldinAShahSRGeneration of chordoma cell line JHC7 and the identification of brachyury as a novel molecular targetJ Neurosurg2011115476076921699479
  • FernandoRILitzingerMTronoPHamiltonDHSchlomJPalenaCThe T-box transcription factor brachyury promotes epithelial- mesenchymal transition in human tumor cellsJ Clin Invest2010120253354420071775
  • NelsonACPillayNHendersonSAn integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordomaJ Pathol2012228327428522847733
  • NibuYJosé-EdwardsDSDi GregorioAFrom notochord formation to hereditary chordoma: the many roles of brachyuryBiomed Res Int2013201382643523662285
  • YangCSchwabJHSchoenfeldAJA novel target for treatment of chordoma: signal transducers and activators of transcription 3Mol Cancer Ther2009892597260519723879
  • LeLPNielsenGPRosenbergAERecurrent chromosomal copy number alterations in sporadic chordomasPloS One201165e1884621602918
  • ShalabyAAPresneauNIdowuBDAnalysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomasMod Pathol2009228996100519407855
  • PillayNPlagnolVTarpeyPSA common single-nucleotide variant in T is strongly associated with chordomaNat Genet201244111185118723064415
  • VargaPFisherCRhinesLPrognostic significance of T gene SNP s2305089 in individuals with spinal column chordomaPoster presented at: AACR Annual Meeting 2014April 5–9, 2014San Diego, CA
  • ZhangLGuoSSchwabJHTissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordomaPloS One201389e7585124086644
  • KalluriRWeinbergRAThe basics of epithelial-mesenchymal transitionJ Clin Invest200911961420142819487818
  • TamWLWeinbergRAThe epigenetics of epithelial-mesenchymal plasticity in cancerNat Med201319111438144924202396
  • HuYMintzAShahSRQuinones-HinojosaAHsuWThe FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survivalCarcinogenesis20143571491149924445144
  • SharmaPWagnerKWolchokJDAllisonJPNovel cancer immunotherapy agents with survival benefit: recent successes and next stepsNat Rev Cancer2011111180581222020206
  • PalenaCPolevDETsangKYThe human T-box mesodermal transcription factor brachyury is a candidate target for T-cell-mediated cancer immunotherapyClin Cancer Res20071382471247817438107
  • GschwindAFischerOMUllrichAThe discovery of receptor tyrosine kinases: targets for cancer therapyNat Rev Cancer20044536137015122207
  • HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
  • ShalabyAPresneauNYeHThe role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic targetJ Pathol2011223333634621171079
  • FasigJHDupontWDLaFleurBJOlsonSJCatesJMImmunohistochemical analysis of receptor tyrosine kinase signal transduction activity in chordomaNeuropathol Appl Neurobiol20083419510417973908
  • WeinbergerPMYuZKowalskiDDifferential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignanciesArch Otolaryngol Head Neck Surg2005131870771116103303
  • PtaszyńskiKSzumera-CiećkiewiczAOwczarekJEpidermal growth factor receptor (EGFR) status in chordomaPol J Pathol2009602818719886182
  • ChenZFillmoreCMHammermanPSKimCFWongKKNon-small-cell lung cancers: a heterogeneous set of diseasesNat Rev Cancer201414853554625056707
  • LindénOStenbergLKjellénERegression of cervical spinal cord compression in a patient with chordoma following treatment with cetuximab and gefitinibActa Oncol200948115815918752082
  • LaunaySGChetailleBMedinaFEfficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature reviewBMC Cancer20111142321970335
  • TamboriniEVirdisENegriTAnalysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomasNeuro Oncol201012877678920164240
  • TamboriniEMiselliFNegriTMolecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomasClin Cancer Res200612236920692817145809
  • CasaliPGMessinaAStacchiottiSImatinib mesylate in chordomaCancer200410192086209715372471
  • OrzanFTerreniMRLongoniMExpression study of the target receptor tyrosine kinase of Imatinib mesylate in skull base chordomasOncol Rep200718124925217549375
  • StacchiottiSMarrariATamboriniEResponse to imatinib plus sirolimus in advanced chordomaAnn Oncol200920111886189419570961
  • StacchiottiSLonghiAFerraresiVPhase II study of imatinib in advanced chordomaJ Clin Oncol201230991492022331945
  • SchwabJAntonescuCBolandPCombination of PI3K/mTOR inhibition demonstrates efficacy in human chordomaAnticancer Res20092961867187119528441
  • PresneauNShalabyAIdowuBPotential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathwayBr J Cancer200910091406141419401700
  • HanSPolizzanoCNielsenGPHornicekFJRosenbergAERameshVAberrant hyperactivation of akt and mammalian target of rapamycin complex 1 signaling in sporadic chordomasClin Cancer Res20091561940194619276265
  • DaviesJMRobinsonAECowdreyCGeneration of a patient-derived chordoma xenograft and characterization of the phosphoproteome in a recurrent chordomaJ Neurosurg2014120233133624286145
  • ShragerJTenenbaumJMRapid learning for precision oncologyNat Rev Clin Oncol201411210911824445514
  • Ricci-VitianiLRunciDD’AlessandrisQGChemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycinNeoplasia201315777378223814489
  • Akhavan-SigariRGaabMRRohdeVExpression of vascular endothelial growth factor receptor 2 (VEGFR-2), inducible nitric oxide synthase (iNOS), and Ki-M1P in skull base chordoma: a series of 145 tumorsNeurosurg Rev2014371798823999886
  • AsklundTSandströmMShahidiSRiklundKHenrikssonRDurable stabilization of three chordoma cases by bevacizumab and erlotinibActa Oncol201453798098424456503
  • Di MaioSKongEYipSRostomilyRConverging paths to progress for skull base chordoma: review of current therapy and future molecular targetsSurg Neurol Int201347223776758
  • HofHWelzelTDebusJEffectiveness of cetuximab/gefitinib in the therapy of a sacral chordomaOnkologie2006291257257417202828
  • StacchiottiSTamboriniELo VulloSPhase II study on lapatinib in advanced EGFR-positive chordomaAnn Oncol20132471931193623559153